Subscribe
shutterstock_1891094320_guteksk7
guteksk7 / Shutterstock.com
16 September 2021Big PharmaBen Wodecki

WHO plans to vaccinate Africa with Moderna COVID vaccine hit stumbling block

Just 12 African countries have hit WHO’s 10% vaccination target as supply chain issues worsen

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Moderna unsure of COVID-19 vaccine patent exclusivity
12 August 2020   US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.
Americas
Moderna’s COVID-19 and Zika patent applications to be investigated
8 September 2020   A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Moderna unsure of COVID-19 vaccine patent exclusivity
12 August 2020   US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.
Americas
Moderna’s COVID-19 and Zika patent applications to be investigated
8 September 2020   A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

More on this story

Americas
Moderna unsure of COVID-19 vaccine patent exclusivity
12 August 2020   US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.
Americas
Moderna’s COVID-19 and Zika patent applications to be investigated
8 September 2020   A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York